Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUK private weight-loss injections are priced per pen or per four-week supply, and what you pay varies significantly by provider, dose and what's bundled in. The honest answer for anyone comparing prices: Mounjaro and Wegovy are prescription-only medicines, meaning any legitimate price must include clinical assessment by a qualified prescriber — not just the pen itself. Since Eli Lilly raised Mounjaro's list price in September 2025, typical private monthly costs have been reported across providers at roughly £149–£375 depending on dose and service, though these figures shift and should be treated as context rather than quotes. Reviews you find online often reflect a single price point at one dose, from one period in time, and frequently omit what that price did (or didn't) cover.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's appraisal of tirzepatide (Mounjaro) found average body-weight reductions of around 20–21% over 72 weeks in the SURMOUNT-1 trial, involving 2,539 adults) results that sit among the strongest published for any licensed weight-management medicine. Semaglutide (Wegovy) produced around 15% average weight loss over 68 weeks in the STEP 1 trial, published in the New England Journal of Medicine. Those outcomes were achieved in clinically supervised trials with structured titration, lifestyle support and regular review. They were not achieved by buying the cheapest pen available from an unverified seller. The reason the evidence matters in a price conversation is straightforward: genuine clinical oversight is part of what produces the result. A pen dispensed from a GPhC-registered pharmacy following a real prescriber assessment is not the same product as one that arrives without it, regardless of what the listing says. You can verify any online pharmacy on the GPhC register in under a minute, search by name or registration number before handing over payment details. That single habit filters out a significant share of unsafe sellers.
The lowest prices that appear in comparison articles and review threads tend to be entry-level prices at starter doses, before full titration, and they frequently exclude one or more of: the consultation fee, the prescription fee, delivery, and any form of clinical follow-up. Some services charge separately for each of those. Others include them but limit aftercare to email contact with a customer-service team rather than a prescriber. A dose increase (which most patients will need as treatment progresses) may carry an additional review charge, or may require uploading evidence of weight change that nobody told you to track. Understanding what different providers actually bundle into their pricing gives a clearer picture than comparing headline monthly figures. The MHRA has also warned publicly about counterfeit weight-loss pens sold via social media and unregulated websites, with approximately 20 million doses of illegally traded medicines (around £45 million street value) seized and the first UK illicit manufacturing site for fake tirzepatide pens raided in 2025. The MHRA's Yellow Card scheme accepts reports of suspect sellers as well as side effects. Sellers offering these medicines without a prescription, at prices well below the market, with discount codes attached, are a red flag, not a bargain.
nume is not the cheapest provider. That is a deliberate choice. One transparent price covers the free consultation, the prescriber's clinical review, the prescription, the medicine, and free next-working-day tracked delivery. There are no add-ons billed separately, no subscription that renews automatically, and no penalty for pausing. Every repeat order is reviewed by a prescriber before it goes out, not rubber-stamped. Our clinical team is GPhC-registered and our pharmacy holds GPhC premises registration 9012878, verifiable at the GPhC register link above. For a prescription medicine, the cheapest listing answers the wrong question. The right question is whether the service dispensing it has the clinical infrastructure to do so safely, can verify your identity and weight, will flag contraindications, and will be reachable if something changes. You can read more about how weight-loss injections work and what to expect from a regulated service, or explore the legitimate routes to accessing treatment if cost is a genuine barrier. NHS access is also an option for some people, the eligibility criteria are strict and phased, but understanding the NHS route is worth doing before committing to private treatment. If you are comparing private providers, our guide to finding the cheapest weight loss injections without compromising on safety sets out what to look for, and if you want to understand how individual pens compare on cost, the breakdown of the cheapest weight loss injection available in the UK covers the key differences. Current treatment pricing at nume is shown on the treatment page. Check your eligibility there and a prescriber will review your consultation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.